Suppr超能文献

以再生障碍性贫血为首发表现的系统性红斑狼疮成功用利妥昔单抗治疗。

The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.

机构信息

Department of Internal Medicine, Baqiyatallah University of Medical Sciences, Tehran, Islamic Republic of Iran.

出版信息

Clin Rheumatol. 2012 Feb;31(2):381-4. doi: 10.1007/s10067-011-1878-z. Epub 2011 Oct 21.

Abstract

Hematologic disorders are common in autoimmune diseases. First presentation of systemic lupus erythematosis with aplastic anemia is extremely rare. We report a patient with the diagnosis of secondary aplastic anemia associated with lupus. All routine medications were not effective. She received Rituximab and her response was satisfactory. Her hematologic parameters were within normal range until last follow-up, six months after therapy was initiated with Rituximab. Review of literature displayed 23 cases of acquired aplastic anemia secondary to systemic lupus erythematosis; however, this is the first time the new drug therapy was used for the treatment.

摘要

血液系统疾病在自身免疫性疾病中较为常见。再生障碍性贫血作为系统性红斑狼疮的首发表现极为罕见。我们报告了一例诊断为再生障碍性贫血相关狼疮的患者。所有常规药物治疗均无效。该患者接受了利妥昔单抗治疗,疗效满意。她的血液学参数在开始利妥昔单抗治疗后 6 个月的最后一次随访时均处于正常范围内。文献复习显示,有 23 例获得性再生障碍性贫血继发于系统性红斑狼疮,但这是首次使用新型药物进行治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验